These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 25644440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
    Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H.
    J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
    Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H.
    Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
    Galvan-Turner VB, Chang J, Ziogas A, Bristow RE.
    Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014.
    Villanueva C, Chang J, Ziogas A, Bristow RE, Vieira VM.
    Cancer Epidemiol; 2020 Dec; 69():101825. PubMed ID: 33022472
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
    Bristow RE, Chang J, Villanueva C, Ziogas A, Vieira VM.
    Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
    Lee JY, Kim TH, Suh DH, Kim JW, Kim HS, Chung HH, Park NH, Song YS, Kang SB.
    Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA.
    J Natl Cancer Inst; 2013 Jun 05; 105(11):823-32. PubMed ID: 23539755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Spatial-Temporal Trends in Ovarian Cancer Outcomes in California.
    Villanueva C, Chang J, Ziogas A, Bristow RE, Vieira VM.
    JNCI Cancer Spectr; 2022 Nov 01; 6(6):. PubMed ID: 36238987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.